MENU

IGMS IGM Biosciences Forecast, Technical & Fundamental Analysis

a biotechnology company, which develops antibodies for the treatment of cancer

Industry Biotechnology
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IGMS is expected to report earnings to fall 27.33% to -73 cents per share on March 27

IGM Biosciences IGMS Stock Earnings Reports
Q4'24
Est.
$-0.73
Q3'24
Missed
by $0.21
Q2'24
Missed
by $0.75
Q1'24
Missed
by $0.02
Q4'23
Est.
$-1.01
The last earnings report on November 08 showed earnings per share of -100 cents, missing the estimate of -80 cents. With 219.83K shares outstanding, the current market capitalization sits at 422.20M.
A.I. Advisor
published General Information

General Information

a biotechnology company, which develops antibodies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
325 East Middlefield Road
Phone
+1 650 965-7873
Employees
224
Web
https://www.igmbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

IGMS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with ABCL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
+1.08%
ABCL - IGMS
39%
Loosely correlated
-2.45%
FATE - IGMS
38%
Loosely correlated
-6.00%
GBIO - IGMS
37%
Loosely correlated
-6.03%
NTLA - IGMS
36%
Loosely correlated
-1.87%
TRDA - IGMS
36%
Loosely correlated
+2.44%
More